JCX-8-23 (May 09, 2023)
Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
Related Publications
-
JCX-23-25 (May 13, 2025)
Distribution Of The Estimated Revenue Effects Of The Tax Provisions Of The Chairman's Amendment In The Nature Of A Substitute To The Budget Reconciliation Legislative Recommendations Related to Tax
view details -
JCX-22-25R (May 13, 2025)
Estimated Revenue Effects Of Provisions To Provide For Reconciliation Of The Fiscal Year 2025 Budget
view details -
JCX-21-25 (May 12, 2025)
Description Of The Tax Provisions Of The Chairman’s Amendment In The Nature Of A Substitute To The Budget Reconciliation Legislative Recommendations Related To Tax
view details